Back
Innovent Biologics Vs. CASI Pharmaceuticals Industry Stock Comparison
Buy
69
IVBXF
Innovent Biologics
Last Price:
4.86
Seasonality Move:
4.59%
Sell
20
CASI
CASI Pharmaceuticals
Last Price:
3.11
Seasonality Move:
4.53%
Buy
69
Innovent Biologics (IVBXF)
is a Buy
Is Innovent Biologics a Buy, Sell or Hold?
- The current Innovent Biologics [IVBXF] share price is $4.86. The Score for IVBXF is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- IVBXF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $3.12. The Score for CASI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CASI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IVBXF Stock Price Chart
What is Innovent Biologics's stock price today?
-
The Innovent Biologics share price today is $4.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVBXF is experiencing slight buying pressure.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $3.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.
IVBXF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 46.31 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CASI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 33.06 | Sell |
Chaikin Money Flow: | -48354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.65 - 5.59) | Sell |
Bollinger Bands (100): | (4.9 - 6.86) | Sell |
IVBXF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.85 | Buy |
20-day SMA: | 4.81 | Buy |
50-day SMA: | 5.22 | Sell |
200-day SMA: | 5.09 | Sell |
8-day EMA: | 4.85 | Buy |
20-day EMA: | 4.86 | Sell |
50-day EMA: | 5.05 | Sell |
200-day EMA: | 5.11 | Sell |
CASI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.48 | Sell |
20-day SMA: | 4.37 | Sell |
50-day SMA: | 5.2 | Sell |
200-day SMA: | 4.83 | Sell |
8-day EMA: | 3.56 | Sell |
20-day EMA: | 4.17 | Sell |
50-day EMA: | 4.96 | Sell |
200-day EMA: | 5.09 | Sell |
Innovent Biologics Earnings Growth & IVBXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Innovent Biologics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CASI Pharmaceuticals Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |